These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 36181709)
1. Metabolic regulation by prostaglandin E Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709 [TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y Front Immunol; 2018; 9():501. PubMed ID: 29593738 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1. Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818 [TBL] [Abstract][Full Text] [Related]
8. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells. Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281 [TBL] [Abstract][Full Text] [Related]
9. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947 [TBL] [Abstract][Full Text] [Related]
11. Role of EP2 and EP4 receptors in airway microvascular leak induced by prostaglandin E2. Jones VC; Birrell MA; Maher SA; Griffiths M; Grace M; O'Donnell VB; Clark SR; Belvisi MG Br J Pharmacol; 2016 Mar; 173(6):992-1004. PubMed ID: 26639895 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation. Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells. Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833 [TBL] [Abstract][Full Text] [Related]
16. Expression of trophoblast derived prostaglandin E2 receptor 2 (EP2) is reduced in patients with recurrent miscarriage and EP2 regulates cell proliferation and expression of inflammatory cytokines. Peng L; Ye Y; Mullikin H; Lin L; Kuhn C; Rahmeh M; Mahner S; Jeschke U; von Schönfeldt V J Reprod Immunol; 2020 Nov; 142():103210. PubMed ID: 33011635 [TBL] [Abstract][Full Text] [Related]
17. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. Holt DM; Ma X; Kundu N; Collin PD; Fulton AM J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906 [TBL] [Abstract][Full Text] [Related]